Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Trzebnica
Clinical trial register · Poland

Clinical Trials in Trzebnica, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 1315 Krakow 882 Poznan 705 Gdansk 657 Lodz 619
Narrow the registerReset
Recruitment status
Phase
Site location
Warsaw1315 Krakow882 Poznan705 Gdansk657 Lodz619
All 264 locations
Target enrolment
to

Trials with a site in Trzebnica

11 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Pfizer
Phase 3
1,200
Milówka, Dziekanów Leśny, Krakow, Tarnów, Trzebnica
2026-06-15
Recruiting
Pfizer
Phase 3
2,400
Krakow, Milówka, Bydgoszcz, Dziekanów Leśny, Poznan, Torun, Trzebnica, Wroclaw
2026-05-04
Recruiting
Kymera Therapeutics, Inc.
Phase 2
264
Bialystok, Gdansk, Lodz, Poznan, Sosnowiec, Tarnów, Trzebnica, Wroclaw
2026-01-28
Active, closed
Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)
Phase 2
66
Rzeszów, Trzebnica
2025-06-03
Active, closed
Sanofi
Phase 3
1,092
Bydgoszcz, Torun, Krakow, Trzebnica, Wroclaw, Warsaw, Łomianki, Siemianowice Śląskie
2025-05-22
Recruiting
Antigravity Treadmill After Joint Arthroplasty
NCT07040878Arthropathy, Osteoarthritis
Wroclaw University of Health and Sport Sciences
Not applicable
60
Trzebnica
2025-05-15
Not yet open
Szpital im. Św. Jadwigi Śląskiej
Observational
150
Trzebnica
2024-12
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 1/2
750
Bydgoszcz, Trzebnica, Lodz, Warsaw, Siemianowice Śląskie
2024-11-05
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Trzebnica, Wroclaw, Lodz, Bia?ystok, Bydgoszcz, Chojnice, Gdynia, Grudzadz
2023-06-28
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-poland/city/trzebnica

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in Trzebnica.

How many clinical trials are recruiting in Trzebnica?

6 of the 11 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Trzebnica), 11 studies
PhaseStudiesRecruitingShare
Phase 36454.5%
Phase 22118.2%
Not applicable119.1%
Observational109.1%
Phase 1/2109.1%

Most active sponsors

Lead sponsors with the most studies (Trzebnica)
Lead sponsorStudiesRecruiting
GlaxoSmithKline22
Pfizer22
Hoffmann-La Roche10
Kymera Therapeutics, Inc.11
Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)10
Sanofi10
Sanofi Pasteur, a Sanofi Company10
Szpital im. Św. Jadwigi Śląskiej10
Wroclaw University of Health and Sport Sciences11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.